JAK2 and retinoblastoma: Moreover, RNF6 promotes RB cell surviving drug treatment through JAK2/STAT3 pathway, and overexpression of RNF6 in drug-sensitive RB cells could render the cells resistant to multiple chemotherapeutical drugs.